New Pancreatic Cancer Treatment Shows Promising Results in Combination with Chemotherapy
Pancreatic cancer remains one of the most challenging malignancies to treat, with limited options and poor survival rates despite advances in oncology. For decades, standard chemotherapy regimens like FOLFIRINOX and gemcitabine-based therapies have formed the backbone of treatment, yet outcomes remain modest, particularly in advanced stages. Recent developments, although, suggest a shift in the therapeutic … Read more
